Matches in Wikidata for { <http://www.wikidata.org/entity/Q64184034> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q64184034 description "clinical trial" @default.
- Q64184034 description "ensayu clínicu" @default.
- Q64184034 description "klinisch onderzoek" @default.
- Q64184034 description "клінічне випробування" @default.
- Q64184034 name "Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma" @default.
- Q64184034 type Item @default.
- Q64184034 label "Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma" @default.
- Q64184034 prefLabel "Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma" @default.
- Q64184034 P1050 Q64184034-A0DE76E7-3FA8-4759-AAB1-3DEA29E06715 @default.
- Q64184034 P1132 Q64184034-F6328F63-1568-403F-A6BD-EF1884779B2A @default.
- Q64184034 P1476 Q64184034-2EFFBDEB-BFB4-47B5-A773-20902C772603 @default.
- Q64184034 P17 Q64184034-07BCF634-6012-43FD-8DFF-2D5A60142F32 @default.
- Q64184034 P17 Q64184034-409C22DB-FD42-476C-93A6-6280FDFEB9BB @default.
- Q64184034 P17 Q64184034-4E62984F-9150-43CC-9AB2-EB6058A98E3B @default.
- Q64184034 P17 Q64184034-5FFDEA0C-3F1B-4039-BDE3-5FCCD56A10F7 @default.
- Q64184034 P17 Q64184034-6255956F-D212-48C8-A62A-52BD87C5CB4A @default.
- Q64184034 P17 Q64184034-8156C82D-A6A4-4FBE-A831-D54433CD355D @default.
- Q64184034 P17 Q64184034-A0D71728-AC38-41FF-B178-AF4824D3801C @default.
- Q64184034 P17 Q64184034-A1FEDF53-F337-46B2-A6E6-FAAB64319423 @default.
- Q64184034 P17 Q64184034-A28310C3-2EA4-475B-866C-B9B877BADBA7 @default.
- Q64184034 P17 Q64184034-A3555AC4-57B5-4F8D-BF12-1B14725AE25B @default.
- Q64184034 P17 Q64184034-A489C25E-5833-44D1-BADD-B8ECF05CC352 @default.
- Q64184034 P17 Q64184034-ADBD9EF5-4CA4-4B36-9B2E-0C1FE1B98FA1 @default.
- Q64184034 P17 Q64184034-C3B08C01-6B80-4077-BA9F-C47B21AA3735 @default.
- Q64184034 P17 Q64184034-F78BE95F-2792-4579-B2E7-9A69AC3BCBA9 @default.
- Q64184034 P17 Q64184034-FB367AC4-A8E4-4A2E-94BC-E150EA3F910E @default.
- Q64184034 P1813 Q64184034-8ACE26C1-AF21-4446-A36A-B5C33EF0DC9B @default.
- Q64184034 P2899 Q64184034-C9141628-5555-4667-8E48-A736DC7AB3BC @default.
- Q64184034 P3098 Q64184034-B3BC753A-49CD-4727-B552-A8CFEFBAAF20 @default.
- Q64184034 P31 Q64184034-10EBCF70-93A5-48CF-9398-4EB3C1A2742C @default.
- Q64184034 P4135 Q64184034-DE602784-0556-405B-800B-BE5CA8C6FAB1 @default.
- Q64184034 P580 Q64184034-5F38BDC7-43B5-4752-A83F-BA15A2FAEB74 @default.
- Q64184034 P582 Q64184034-B53A45ED-4D3B-42AA-80D7-F7B0FA678BF5 @default.
- Q64184034 P6099 Q64184034-39028BD8-A0B9-45AD-8445-7F1077792E44 @default.
- Q64184034 P8363 Q64184034-3252FB75-39FC-46B5-9393-C7FC3589C669 @default.
- Q64184034 P1050 Q35869 @default.
- Q64184034 P1132 "+964" @default.
- Q64184034 P1476 "A Multicentre, Double-blind, Randomized, Placebo Controlled, Parallel Group, Phase 3, Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (DESTINATION)" @default.
- Q64184034 P17 Q142 @default.
- Q64184034 P17 Q155 @default.
- Q64184034 P17 Q16 @default.
- Q64184034 P17 Q183 @default.
- Q64184034 P17 Q212 @default.
- Q64184034 P17 Q258 @default.
- Q64184034 P17 Q30 @default.
- Q64184034 P17 Q36 @default.
- Q64184034 P17 Q40 @default.
- Q64184034 P17 Q408 @default.
- Q64184034 P17 Q414 @default.
- Q64184034 P17 Q43 @default.
- Q64184034 P17 Q801 @default.
- Q64184034 P17 Q865 @default.
- Q64184034 P17 Q881 @default.
- Q64184034 P1813 "DESTINATION" @default.
- Q64184034 P2899 "+13" @default.
- Q64184034 P3098 "NCT03706079" @default.
- Q64184034 P31 Q30612 @default.
- Q64184034 P4135 "+81" @default.
- Q64184034 P580 "2019-01-07T00:00:00Z" @default.
- Q64184034 P582 "2021-12-22T00:00:00Z" @default.
- Q64184034 P6099 Q42824827 @default.
- Q64184034 P8363 Q78089383 @default.